Exposure of the developing brain to cocaine can cause neurological and behavioral abnormalities in babies born to mothers who use the drug during pregnancy. In a study research published in this week's PLoS Medicine, Chun-Ting Lee and colleagues at the U.S. National Institutes of Heath— who note that cocaine use occurs in several hundred thousand pregnancies per year in the United States alone — investigated the mechanism of cocaine's effect on fetal brain development. They found that a byproduct of cocaine metabolism inhibits the development of nerve cells by interfering with a specific protein, cyclin A, which regulates cell division. The researchers found that this interference occurred because cocaine metabolism caused oxidative stress within the endoplasmic reticulum, part of the cellular apparatus for producing proteins. They also showed that treatment of pregnant rats with cimetidine, a drug used to reduce stomach acid secretion and interferes with the enzymes that metabolize cocaine, counteracted the inhibition of neural cell development caused by cocaine exposure in the rat fetuses. These results suggest the possibility that treatments to block the effect of cocaine on cyclin A may provide a way to protect fetal brain development when a pregnant woman is unable to stop using cocaine. Further research would be necessary to determine whether such an approach could be safe and effective in human pregnancies, the researchers say
In a related perspective on the implications of the research, Steven Hyman of Harvard University, who was not involved in the study, says the findings are exciting but also notes "the complexity of factors that might contribute to cognitive and emotional abnormalities in children exposed to cocaine and other dangerous drugs in utero."
Citation: Lee C-T, Chen J, Hayashi T, Tsai S-Y, Sanchez JF, et al. (2008) A mechanism responsible for the inhibition of neural progenitor cell proliferation by cocaine. PLoS Med 5(6): e117.
PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050117
PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-05-06-lee.pdf
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
United States of America
+1 410-550-1621 (fax)
Related PLoS Medicine Perspective article:
Citation: Hyman SE (2008) How might cocaine interfere with brain development? PLoS Med 5(6): e130.
PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050130
PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-05-06-hyman.pdf
Department of Neurobiology
Cambridge, MA 02138
United States of America
+1 617 496-5100
+1 617 496-4630 (fax)
About PLoS Medicine
PLoS Medicine is an open access, freely available international medical journal. It publishes original research that enhances our understanding of human health and disease, together with commentary and analysis of important global health issues. For more information, visit http://www.plosmedicine.org
About the Public Library of Science
The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.